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Abstract
Purpose—CRISPR-Cas systems are prokaryotic immune systems against invading nucleic acids 
that adapt as new environmental threats arise. There are emerging examples of CRISPR-Cas 
functions in bacterial physiology beyond their role in adaptive immunity. This highlights the 
poorly understood, but potentially common, moonlighting functions of these abundant systems. 
We propose that these non-canonical CRISPR-Cas activities have evolved to respond to stresses at 
the cell envelope.
Recent findings—Here, we discuss recent literature describing the impact of the extracellular 
environment on the regulation of CRISPR-Cas systems, and the influence of CRISPR-Cas activity 
on bacterial physiology. The described non-canonical CRISPR-Cas functions allow the bacterial 
cell to respond to the extracellular environment, primarily through changes in envelope 
physiology.
Summary—This review discusses the expanding non-canonical functions of CRISPR-Cas 
systems, including their roles in virulence, focusing mainly on their relationship to the cell 
envelope. We first examine the effects of the extracellular environment on regulation of CRISPR-
Cas components, and then discuss the impact of CRISPR-Cas systems on bacterial physiology, 
focusing on their roles in influencing interactions with the environment including host organisms.
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Introduction
Prokaryotic organisms have evolved unique, adaptive, nucleic acid restriction machineries to 
prevent the uptake of mobile genetic elements, such as those derived from bacteriophages 
and plasmids(1). Termed CRISPR (clustered, regularly interspaced, short, palindromic 
repeats) - Cas (CRISPR-associated) systems, these RNA-guided endonuclease machineries 
canonically act in a sequence-specific fashion to cleave foreign DNA or RNA targets(2-5). 
This protects cells from exposure to potentially harmful genetic elements(2-4). Beyond this 
well-established function, CRISPR-Cas systems have been observed to play alternative roles 
in physiology. These moonlighting functions of CRISPR-Cas systems include roles in 
oxidative stress tolerance, antibiotic resistance, extracellular structure formation, DNA 
repair, and host-microbe interactions.
The molecular mechanism of many alternative CRISPR-Cas functions has not yet been fully 
elucidated, but may utilize a similar activity to that used in canonical targeting of foreign 
nucleic acids (6, 7). The signature component of CRISPR-Cas systems is the CRISPR array, 
composed of short, repetitive, and often palindromic sequences(8). These repeats are 
interspaced by short, unique, spacer sequences that are complementary to different nucleic 
acid targets (2, 9, 10). In most systems, the CRISPR array is transcribed as a single 
transcript (the pre-crRNA array) and is cleaved into small targeting RNAs (crRNAs) 
(11-14). These crRNAs form complexes with Cas proteins, which are encoded in adjacent, 
conserved operons (4). The complexes are capable of sequence-specific interaction with 
foreign nucleic acids (6). Upon hybridization of the crRNA to its target sequence, 
endonuclease activity of the associated Cas protein(s) is triggered, resulting in target 
cleavage (6). CRISPR-Cas systems are diverse and can be grouped into three main subtypes 
(types I,II, and III) defined by the unique Cas proteins used in crRNA processing and 
targeting/cleavage(1). While the type I and III systems use multimeric protein complexes for 
these processes, the type II system requires a single Cas protein, Cas9, as well as a unique 
accessory RNA, the trans-activating CRISPR RNA (tracrRNA) (1, 13, 15, 16). Uniquely, 
CRISPR-Cas systems can also acquire new spacer sequences within the CRISPR array as 
the nucleic acid threats (such as bacteriophages) in the environment change (2, 17).
Interestingly, many of the alternative activities (not involving the targeted degradation of 
foreign nucleic acid) of CRISPR-Cas systems are linked to processes occurring at the 
bacterial envelope. Herein, we present a CRISPR view of how CRISPR-Cas systems 
monitor and respond to stresses at the cell envelope, allowing bacteria to counteract not only 
bacteriophage infection, but also diverse insults such as antibiotics and host defenses. First, 
we discuss the transcriptional regulation of CRISPR-Cas systems in response to 
environmental changes signaled by the status of the bacterial envelope. We then describe the 
current understanding of how CRISPR-Cas systems regulate bacterial physiology, largely 
through changes at the cell surface, to promote resistance to environmental stresses. Finally, 
we highlight unanswered questions in the field of CRISPR-Cas biology, the exploration of 
which will provide insight into the evolution of CRISPR-Cas systems and the origins of 
their increasingly broad functions in bacterial physiology.
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Activation and function of CRISPR-Cas systems in response to envelope 
stress
Since CRISPR-Cas systems target nucleic acids that have entered the cell through the 
envelope, it is interesting to note that their transcriptional activation often occurs directly, 
and indirectly, in response to envelope stresses (Figure 1). The most explicit example of this 
occurs during bacteriophage infection. It is logical to think that upon bacteriophage 
adsorption and DNA injection the envelope is disrupted, resulting in an envelope stress 
response(18-20). Concomitantly, activation of CRISPR-Cas transcription has been observed, 
suggesting that the cell actively senses the status of the envelope in order to respond to 
invading threats(21, 22). Furthermore, it has been observed that membrane protein 
dysregulation is capable of inducing the increased expression of CRISPR-Cas systems. For 
instance, in Escherichia coli, the BaeSR extracytoplasmic stress response regulator acts to 
activate its CRISPR-Cas system when the bacterial envelope is perturbed (23). Furthermore, 
the transcriptional regulator H-NS is an inhibitor of CRISPR-Cas expression. Upon an 
envelope stress response, H-NS is inhibited, leading to an upregulation of a CRISPR-Cas 
system in Salmonella enterica and E. coli (24, 25). Additionally, high temperatures result in 
misfolding of membrane proteins and an envelope stress response leading to activation of 
heat shock protein G (HtpG) (26, 27). HtpG has subsequently been shown to activate 
transcription of CRISPR-Cas systems in E. coli (27). Thus, CRISPR-Cas systems can be 
primed by stress at the envelope, likely at least in part to counter actin coming foreign 
nucleic acids.
In line with this idea, a recent study of Streptococcus mutans, a cause of tooth decay, 
revealed that expression of the Type II-A CRISPR-Cas system was negatively affected by 
the stress response regulator VicK/R two-component system, which also positively regulated 
the expression of its Type I-C system (28-30). Additionally, it was observed that both of 
these CRISPR-Cas systems play a role in temperature stress tolerance. CRISPR-Cas locus 
deletion mutants exhibited reduced survival after heat exposure, and surprisingly, double 
mutants in both loci had a greater sensitivity to high temperature than mutants from either 
locus alone, suggesting independent activity of each system (30). Furthermore, CRISPR-Cas 
mutants in the type II-A system, but not the Type I-C system, displayed reduced growth 
upon exposure to membrane stress (detergents) as well as oxidative stress (paraquat and 
hydrogen peroxide) (30). Together, these data directly link CRISPR-Cas function to 
envelope stresses, and further suggest that VicK/R may differentially regulate each 
CRISPR-Cas system under specific conditions. This raises the questions of whether these 
systems work together in nucleic acid defense as well, if they have distinct defense activities 
beyond adaptive immunity, or if they diverged in function to fulfill distinct regulatory roles, 
perhaps by altering the envelope. Exactly how these CRISPR-Cas systems regulate stress 
tolerance remains to be elucidated, and continued study of this phenomenon in diverse 
bacteria will be necessary to identify common themes. It is reasonable to postulate that this 
occurs through physiological changes at the envelope, which acts as the frontline to 
counteract environmental stressors.
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CRISPR-Cas control of population behaviors
In addition to roles in the envelope stress response, CRISPR-Cas systems have been 
implicated in complex population behaviors that involve extensive envelope alterations, 
such as biofilm formation and fruiting body development (Figure 2). Before CRISPR-Cas 
systems were identified, three genes encoded by the Gram-negative saprophytic bacterium 
Myxococcusxanthus, were found to be necessary for sporulation and fruiting body 
development (31-33). Interestingly, the three genes, devT, devR, and devS, respectively 
correspond to cas8, cas7, and cas5from a type I CRISPR-Cas system. In the absence of devT 
(cas8), M. xanthus displayed delayed cellular aggregation, sporulation, and chemotaxis, as 
well as decreased transcript levels for a fruiting body transcriptional activator(31). While the 
mechanism of regulation has not been fully elucidated, the M. xanthus CRISPR array 
encodes two spacers that have identity to endogenous sequences on the bacterial 
chromosome. One has identity to an integrase of a Myxococcus bacteriophage, while the 
other has identity to a casgene in a different CRISPR-Cas locus, raising the intriguing 
possibility that the CRISPR-Cas system regulates endogenous targets (33). However, 
whether the CRISPR array itself is required for control of the aforementioned processes 
remains unknown.
M. xanthus regulation of fruiting body formation is further influenced by a type III-B 
CRISPR-Cas locus, which also regulates exopolysaccharide (EPS) production and type IV 
pili mediated chemotaxis (34). Not only is crRNA processing required for this regulatory 
activity, but the associated cas genes are as well (34). Further studies are needed to 
determine if and how the type I and III systems in M. xanthus interact to regulate fruiting 
body formation, as well as the mechanism of CRISPR-Cas mediated EPS regulation. It will 
be interesting to determine whether these functions evolved due to pressures to restrict 
mobile genetic elements, broader stresses at the envelope, or from entirely different 
environmental pressures.
Another population behavior involving extensive envelope changes, biofilm formation, is 
regulated by the type I CRISPR-Cas system in the opportunistic pathogen Pseudomonas 
aeruginosa (35, 36). A spacer within the P. aeruginosa CRISPR array has sequence 
similarity to a gene within a chromosomally integrated prophage (36). The CRISPR-Cas 
system interaction with this chromosomal element is necessary to represss warming motility 
and biofilm formation (35, 36). While it is not known how repression occurs, it is 
established as a sequence-specific activity requiring all interference components of this 
CRISPR-Cas system (36, 37). Given the importance of biofilm formation to antibiotic 
resistance and pathogenesis in P. aeruginosa, it is likely that this CRISPR-Cas system plays 
an important role in mediating infection of eukaryotic hosts.
CRISPR-Cas mediated regulation of host-pathogen interactions
While all bacteria encounter numerous environmental stresses, those bacteria that interact 
with eukaryotes, particularly mammalian hosts, are subjected to a variety of 
microenvironments and stressors as they traffic through the host and encounter the immune 
system (Figure 2). It is therefore an exciting proposition that CRISPR-Cas systems may be 
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utilized in response to these host-derived stresses and ultimately mediate host-microbe 
interactions.
Recently, it has been observed that CRISPR-Cas systems can modulate host immune 
evasion. The intracellular pathogen Francisellanovicida upregulates its type II-B CRISPR-
Cas system in the phagosome of host macrophages, a stressful environment containing a 
plethora of host defenses that attack the bacterial envelope (38). Components of this system 
(Cas9, tracrRNA, and a small CRISPR-Cas associated RNA [scaRNA]) regulate the 
production of an endogenous bacterial lipoprotein (BLP), a process necessary for 
strengthening the bacterial envelope (38, 39). Loss of these components results in increased 
envelope permeability and subsequently increases susceptibility to membrane damaging 
compounds, such as those found in the macrophage phagosome (39). Furthermore, 
regulation of the BLP dramatically alters how F. novicida survives within its mammalian 
host. In fact, cas9 mutants are attenuated in a mouse model by 103-104 fold compared to 
wild-type bacteria (38). Cas9 and its associated RNAs enable evasion of the host innate 
immune response through two distinct pathways, both of which originate due to changes at 
the membrane. In the absence of Cas9, the BLP transcript is de-repressed, and the bacteria 
are detected by the host pattern recognition receptor (PRR) Toll-like receptor 2 (TLR2), 
which initiates a proinflammatory response upon recognition of BLP(38). Additionally, 
repression of the BLP increases envelope integrity and reduces activation of the AIM2/ASC 
inflammasome, a protein complex involved in a programmed host cell death pathway that 
results in loss of Francisella's replicative niche (39). This CRISPR-Cas mediated evasion of 
both TLR2 and the AIM2/ASC inflammasome is critical for the ability of F. novicida to 
cause disease.
Consistent with the idea that CRISPR-Cas systems have evolved functions to mediate 
interactions with eukaryotic hosts, Neisseria meningitidis Cas9 is necessary for intracellular 
survival in human epithelial cells (38). Further, N. meningitidis Cas9 is also required for 
attachment and entry into these cells, processes dependent on surface components, 
suggesting that it may regulate envelope structures in this bacterium (38). Cas9 is likewise 
necessary for attachment and intracellular survival of Campylobacterjejuni, a cause of 
diarrheal disease and Guillain-Barré syndrome, in epithelial cells (40). Furthermore, C. 
jejunicas9 mutants displayed increased surface antibody binding, as well as increased 
envelope permeability and antibiotic susceptibility, all potentially linking Cas9 to the 
regulation of envelope components (40). Finally, it was observed bioinformatically that the 
presence of envelope sialylation correlates with a loss of the type II CRISPR-Cas system in 
multiple bacteria (including N. meningitidis, C. jejuni, and Haemophilus parainfluenzae) 
(40). Taken together, these data provide additional evidence for alternative functions of 
CRISPR-Cas systems in regulating envelope functions in response to environmental 
pressures.
Another example of a CRISPR-Cas system promoting host-microbe interactions is observed 
in the Gram-negative bacterium Xenorhabdus nematophila. Here, an orphan CRISPR RNA, 
termed NilD, is necessary for X. nematophila to colonize Steinemema spp. nematodes, a 
symbiotic relationship that facilitates the pathogenesis of these nematodes for their insect 
hosts (41). This is the first example of a CRISPR-Cas system modulating a mutualistic and 
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tripartite interaction, and sheds light on the under explored complexity of CRISPR-Cas 
functions in broader ecological niches. Interestingly, this CRISPR-Cas system is expressed 
at a higher level in iron limiting conditions, furthering the concept that these machineries 
respond to extracellular changes and to events that are tightly regulated at the bacterial 
envelope (41). Additionally, the role of the crRNA from this system in colonization is 
independent of the effector protein Cas3, suggesting that the NilD CRISPR RNA has a 
unique function not involving canonical CRISPR-Cas activity (41). Further studies to 
elucidate the molecular mechanism of NilD-mediated nematode colonization will shed light 
not only on envelope changes that facilitate colonization, but also on how orphan crRNAs 
can potentially function as regulatory elements.
Similar to NilD, it was observed that the cas2 gene of the type II-B CRISPR-Cas system of 
Legionella pneumophila was required for intracellular survival within amoebae, and that 
cas2 was upregulated during intra-amoeba growth (42). Interestingly, no other cas gene was 
required, and cas2 was not required for growth in broth culture or intracellular infection of 
macrophages (42). Furthermore, expression of cas2 in a L. pneumophila strain that lacks a 
CRISPR-Cas system increased the strain's ability to replicate within amoebae, further 
indicating that Cas2 can act independently of canonical CRISPR-Cas function (43). Cas2 
orthologs have RNase and/or DNase activity, depending on the organism, and are involved 
in spacer acquisition (17, 44-47). Cas2 nuclease activity is dependent on a single catalytic 
residue, which is also required for L. pneumophila intra-ameobal survival (43). In. L. 
pneumophila, not only is Cas2 RNase activity more efficient than DNase activity, but each 
requires a different divalent ion (Mg2+ or Mn2+, respectively)(43). Thus, preferred nuclease 
activity may change with shifts in the bacterial environment. It is unclear which nuclease 
activity promotes survival in amoebae, and a comparison of the ion concentrations in 
different growth environments may shed light on this difference. Likewise, the precise role 
of Cas2 in promoting intracellular survival is still unknown; it is tempting to consider that 
Cas2 has functions in mRNA regulation, particularly given that residues in its nuclease 
motif are essential for its role in intra-amoeba survival. Studies to observe which nucleic 
acids associate with Cas2 in different stages and contexts of Legionella growth, as well as 
determining the environmental cues governing the independent regulation of this Cas 
protein, will significantly enhance the understanding of CRISPR-Cas function as a regulator 
of intracellular survival.
Are CRISPR-Cas systems more broadly involved in stress responses?
Intriguingly, CRISPR-Cas systems are also regulated by a broad range of environmental 
conditions not necessarily linked to envelope stress (Figure 1). For instance, in nutrient rich 
conditions, the leucine-responsive protein (Lrp) represses CRISPR-Cas expression in 
Salmonella enterica serovar Typhi (24). However, upon starvation, Lrp is inactivated and 
may de-repress CRISPR-Cas transcription (24). Additionally, the regulator LeuO is an 
activator of CRISPR-Cas expression in S. enterica and Escherichia coli (24, 25, 48). LeuO 
is active under low phosphate and stationary phase conditions, further suggesting that 
starvation responses can increase CRISPR-Cas expression (49, 50). It is interesting to 
speculate that expression of CRISPR-Cas systems may also be tied to nutrient conditions 
since prokaryotic organisms may actively seek out nucleic acids as a nutrient source (51). 
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While starvation is a stress in itself, it can indirectly result in dysregulation of membrane 
composition, as well as serve as a signal for prophages to become lytic (52, 53). The same is 
true for oxidative and osmotic stress, which have been shown to activate CRISPR-Cas 
systems and cause broad stress to the cell, including at the membrane (54, 55). Therefore, it 
is unclear whether there is a universal link between induction of CRISPR-Cas systems and 
envelope stress, or if these machineries may more broadly be induced by diverse stresses. In 
total, these examples provide further links between CRISPR-Cas activation and the response 
to environmental cues, which may occur through either their canonical or alternative 
functions.
In addition, CRISPR-Cas systems may act to regulate the cell's response against other 
diverse environmental stresses(38, 41, 54-57). For example, in E. coli, both the CRISPR 
array and Cas1 can participate in mediating DNA repair, while in Thermoproteustenax, a 
CRISPR-Cas system is activated in response to DNA damaging UV light (55, 56). 
Therefore, CRISPR-Cas systems may be responsible for alleviating the effects of stresses 
that damage the chromosome. In another example, the orphan CRISPR locus in 
Listeriamono cytogenes, rliB, acts to upregulate the production of the iron transport system 
feoAB, further demonstrating that CRISPR-Cas systems mediate physiological changes that 
are likely in response to environmental stress (57). Overall, these observations demonstrate 
that CRISPR-Cas systems may have evolved multiple functions to not only be activated in 
response to diverse environmental stress, but also to play active roles in preventing stress-
promoted damage.
Conclusion
CRISPR-Cas systems are complex machineries that act to protect the cell against potentially 
harmful mobile genetic elements. As such, it would be efficient to regulate expression of 
these systems to times when the threat of such elements is imminent. Accordingly, there are 
now multiple examples of increased activation of CRISPR-Cas systems in response to 
envelope stress, such as bacteriophage binding and envelope disruption, ultimately enabling 
cells to activate defenses against potential genetic threats.
We have summarized numerous examples of CRISPR-Cas systems having functions beyond 
defense against foreign nucleic acids, many of which involve regulation of envelope 
physiology and how the cell interacts with its host and environment. It is interesting to 
consider how these non-canonical functions may have arisen. These observed roles could 
have appeared due to independent pressures, or stochastically due to accidental acquisition 
of spacers targeting self. Furthermore, the relationships between CRISPR-Cas system 
subtype and their non-canonical functions are poorly understood. Since some bacterial 
species encode multiple CRISPR-Cas subtypes within the same genome, each unique system 
may represent a fine-tuning of nucleic acid defense, perhaps based on niche and 
environmental cues. Alternatively, the presence of multiple systems may be linked to non-
canonical functions, whereby some systems are preferentially used for nucleic acid defense 
and others to regulate bacterial physiology, or multiple systems facilitate different non-
canonical functions. We hypothesize that clues to these interactions lie at the envelope, and 
that by studying the non-canonical functions of CRISPR-Cas systems from this perspective, 
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we will gain insight into the evolution of both commensal and pathogenic bacteria to defend 
against their own pathogens and survive within their diverse replicative niches.
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Key points
• CRISPR-Cas systems play roles in bacterial gene regulation.
• Regulatory roles of CRISPR-Cas systems are linked to processes occurring at 
the bacterial envelope.
• The ability to respond to envelope stress may have driven the involvement of 
CRISPR-Cas systems in gene regulation
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Figure 1. Activation of CRISPR-Cas systems in response to environmental changes
CRISPR-Cas systems can be activated in response to the broader environmental stressors of 
nutrient starvation, stationary phase growth, and iron limitation. Likewise, CRISPR-Cas 
systems can be activated directly in response to envelope stressors, such as phage infection 
and high temperature. These examples highlight the influence of the extracellular 
environment on the regulation of CRISPR-Cas systems.
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Figure 2. CRISPR-Cas mediated physiological changes
CRISPR-Cas systems influence bacterial physiology, altering population behavior and host-
microbe interactions through events that are centered at the envelope. In 
Francisellanovicida, Cas9, tracrRNA and scaRNA form a complex that represses a bacterial 
lipoprotein mRNA (BLP). Repression of the BLP increases membrane integrity, conferring 
resistance to membrane targeting antibiotics and enabling evasion of the host immune 
system, increasing virulence. Cas9 from Neisseria meningitidis and Cas2 from Legionella 
pneumophila type II systems increase host-cell attachment and intracellular survival. In 
Xenorhabdus nematophila, Cas6 and a CRISPRRNA (crRNA) of the type I-E system are 
required for host colonization. In Myxococcusxanthus, the type III CRISPR-Cas system 
regulates exopolysacchride production (EPS) to enable chemotaxis, while negatively 
effecting fruiting body formation. Conversely, Cas5, Cas7, and Cas8 of its type III CRISPR-
Cas system are necessary for fruiting body formation and sporulation. Finally, in 
Pseudomonas aeruginosa, all interference components of the Type I CRISPR system are 
required for biofilm formation and swarming motility. These examples provide a framework 
for understanding the alternative functions of CRISPR-Cas systems from interactions at the 
prokaryotic envelope.
Ratner et al. Page 14
Curr Opin Infect Dis. Author manuscript; available in PMC 2016 June 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
